Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

Cancer cells are resourceful — they've figured out how to neutralize a toxin they produce (formaldehyde) while keeping a key shield against cell death intact. Researchers at the Josep Carreras Leukaemia Research Institute have cracked the code on how they pull this off, and found that attacking both defenses simultaneously can kill leukemia and solid tumor cells. A potential new treatment strategy may be on the horizon.
Cancer cells produce formaldehyde as a byproduct of growth — and left unchecked, it can damage DNA. Researchers have now discovered how cancer cells neutralize this internal toxin without sacrificing their main defense against a form of cell death called ferroptosis. The key player is a protein called NRF2, which is often overactive in tumors and orchestrates a workaround that keeps cancer cells protected on two fronts simultaneously.
The mechanism works like this: NRF2 ramps up a transporter protein (SLC7A11) that pulls cystine into the cell. Cystine then reacts directly with formaldehyde — bypassing the cell's main protective molecule, glutathione — and produces a stable compound called thioproline. This frees up glutathione to keep doing its other job: preventing ferroptosis. When researchers blocked this system and disrupted glutathione production at the same time, leukemia cells, lung cancer cells, colon cancer cells, and brain tumor cells all died.
Key Takeaways:
Why it matters: This study reveals a previously underappreciated vulnerability in cancer cells — one that spans multiple tumor types. If this dual-blocking strategy proves safe in further studies, it could open a new therapeutic avenue for leukemia and beyond.